
| Serial Number | 87891425 |
| Word Mark | A |
| Filing Date | Tuesday, April 24, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 26, 2023 |
| Registration Number | 7176343 |
| Registration Date | Tuesday, September 26, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 19, 2020 |
| Description of Mark | The mark consists of a dotted "A". |
| Goods and Services | Nutraceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Pharmaceuticals, namely, pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders; Vaccines in the field of veterinary medicine; Therapeutic pharmaceuticals for the purpose of treating animal diseases, animal conditions and animal illnesses in the field of veterinary medicine in the nature of veterinary pharmaceutical preparations for the treatment of autoimmune disorders, oncologic disorders, renal and urinary tract disorders, neurologic disorders, musculoskeletal disorders, infectious disease disorders, dermatologic disorders, ophthalmic disorders, cardiovascular disorders, respiratory disorders, endocrine disorders, metabolic disorders including obesity, gastrointestinal disorders |
| Pseudo Mark | ANIVIVE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Drug discovery services for veterinary medicine; providing pharmaceutical and medical research services and clinical, medical and scientific research information in the field of animal health; analysis services for veterinary medicine, namely, clinical, medical and scientific research; obtaining, recording, analyzing, reporting and modeling data for animal health purposes, namely, electronic monitoring and reporting of clinical information, namely, age, sex, breed, neuter status, body weight, body condition score, blood pressure, heart rate, frequency and character of respiration, appetite, presence or absence of vomiting, activity level, food and water intake, frequency and character of urination and defecation, of animals, using computers or sensors; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for use in database management, for use as a spreadsheet, for word processing, for statistical analysis, data aggregation, data processing, report generation, data sharing, remote data management, remote project management, and data analysis in the field of veterinary medicine for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software for assisting in drug discovery in the nature of managing clinical trials for animal health purposes; platform as a service featuring computer software platforms and providing temporary use of non-downloadable computer software to facilitate ordering and delivery of medications and treatment to animal owners, distributors and veterinary health care providers for animal health purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 3, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, January 5, 2021 |
| First Use In Commerce Date | Tuesday, January 5, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 3, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, November 13, 2018 |
| First Use In Commerce Date | Tuesday, November 13, 2018 |
| Party Name | Anivive Lifesciences, Inc |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Long Beach, CA 90808 |
| Party Name | Anivive Lifesciences, Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Long Beach, CA 90808 |
| Party Name | Anivive Lifesciences, Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Long Beach, CA 90808 |
| Event Date | Event Description |
| Tuesday, September 26, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 26, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 23, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, August 22, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, July 31, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, July 14, 2023 | USE AMENDMENT FILED |
| Friday, July 14, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, March 1, 2023 | ASSIGNED TO EXAMINER |
| Friday, February 3, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 2, 2023 | SOU EXTENSION 5 GRANTED |
| Wednesday, January 11, 2023 | SOU EXTENSION 5 FILED |
| Thursday, January 26, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, January 11, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 21, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 17, 2022 | SOU EXTENSION 4 GRANTED |
| Friday, June 17, 2022 | SOU EXTENSION 4 FILED |
| Friday, June 17, 2022 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 11, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 7, 2022 | SOU EXTENSION 3 GRANTED |
| Friday, January 7, 2022 | SOU EXTENSION 3 FILED |
| Friday, January 7, 2022 | SOU TEAS EXTENSION RECEIVED |
| Saturday, July 3, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 1, 2021 | SOU EXTENSION 2 GRANTED |
| Thursday, July 1, 2021 | SOU EXTENSION 2 FILED |
| Thursday, July 1, 2021 | SOU TEAS EXTENSION RECEIVED |
| Saturday, January 9, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 7, 2021 | SOU EXTENSION 1 GRANTED |
| Thursday, January 7, 2021 | SOU EXTENSION 1 FILED |
| Thursday, January 7, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 14, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 19, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 19, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 29, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, April 13, 2020 | EXPARTE APPEAL TERMINATED |
| Monday, April 13, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 13, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 13, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, April 13, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 13, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 31, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 31, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 31, 2020 | ASSIGNED TO LIE |
| Monday, March 23, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, March 23, 2020 | EX PARTE APPEAL-INSTITUTED |
| Monday, March 23, 2020 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, March 23, 2020 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, September 25, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, September 25, 2019 | FINAL REFUSAL E-MAILED |
| Wednesday, September 25, 2019 | FINAL REFUSAL WRITTEN |
| Tuesday, August 27, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, August 26, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 26, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 4, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, March 4, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, February 11, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, February 11, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 11, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 16, 2018 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, August 16, 2018 | PRIORITY ACTION E-MAILED |
| Thursday, August 16, 2018 | PRIORITY ACTION WRITTEN |
| Tuesday, August 14, 2018 | ASSIGNED TO EXAMINER |
| Friday, May 4, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 3, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 27, 2018 | NEW APPLICATION ENTERED |